Mohammad Sadegh Fallah

Mohammad Sadegh Fallah

Auto-generated profile, based on publicly available information

Mohammad Sadegh Fallah

Kawsar Human Genetics Research Center , Tehran , Iran

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 February 2017 in JMIR Research Protocols
Verified
Journal Article
Open access
MDMaryam S Daneshpour
Maryam S Daneshpour
MFMohammad-Sadegh Fallah
Mohammad-Sadegh Fallah
BSBahareh Sedaghati-Khayat
Bahareh Sedaghati-Khayat
KGKamran Guity
Kamran Guity
DKDavood Khalili
Davood Khalili
FAFereidoun Azizi
Fereidoun Azizi
Cardiometabolic risk factors comprise cardiovascular diseases and/or diabetes, and need to be evaluated in different fields. The primary aim of the Tehran Cardiometabolic Genetic Study (TCGS) is to create a comprehensive genome-wide database of at least 16,000 Tehranians, who are participants of the ongoing Tehran Lipid and Glucose Study (TLGS) cohort. TCGS was designed in collaboration with the Research Institute for Endocrine Sciences and the genetic company deCODE. Participants had already been followed for over a 20-year period for major cardiometabolic-related health events including myocardial infarction, stroke, diabetes mellitus, hypertension, obesity, hyperlipidemia, and familial hypercholesterolemia. The TCGS cohort described here comprises 17,186 (86.3%) of the 19,905 TLGS participants who provided a baseline blood sample that was adequate for plasma and deoxyribonucleic acid analysis. This study is comprised of 849 individuals and 3109 families with at least one member having genotype information. Finally, 5977 males and 7422 females with the total genotyping rate of 0.9854 were genotyped with HumanOmniExpress-24-v1-0 bead chips (containing 649,932 single-nucleotide polymorphism loci with an average mean distance of 4 kilobases). Investigations conducted within the TCGS will seek to identify relevant patterns of genetic polymorphisms that could be related to cardiometabolic risk factors in participants from Tehran. By linking genome-wide data to the existing databank of TLGS participants, which includes comprehensive behavioral, biochemical, and clinical data on each participant since cohort inception in 1999, the TCGS will also allow exploration of gene-gene and gene-environment interactions as they relate to disease status.

1 September 2024 in Iranian Biomedical Journal
Verified
Journal Article
Open access
PDF file
NSNasibeh Soltani
Nasibeh Soltani
ZSZahra Shahbazi
Zahra Shahbazi
MKMorteza Karimipoor
Morteza Karimipoor
MFMohammad Sadegh Fallah
Mohammad Sadegh Fallah
FMFatemeh Zafarghandi Motlagh
Fatemeh Zafarghandi Motlagh
SZSirous Zeinali
Sirous Zeinali
Background: Muscular dystrophy is an inherited disease with clinical and genetic heterogeneity. Muscle weakness is the primary symptom of these disorders that often leads to disability and death. The overall prevalence for all types of muscular dystrophies worldwide is 19.8-25.1 per 100.000 population. Autosomal recessive types of muscular dystrophies are ...

1 January 2026 in Human Mutation
Verified
Journal Article
Open access
PDF file
NSNasibeh Soltani
Nasibeh Soltani
ZSZahra Shahbazi
Zahra Shahbazi
MFMohammad Sadegh Fallah
Mohammad Sadegh Fallah
MKMorteza Karimipoor
Morteza Karimipoor
HBHamideh Bagherian
Hamideh Bagherian
SZSirous Zeinali
Sirous Zeinali
Background: Muscular dystrophies (MDs) are a genetically heterogeneous group of disorders, posing significant diagnostic challenges, especially in populations with high consanguinity. Despite advances in genetic testing, a substantial proportion of patients remain undiagnosed. Whole‐exome sequencing (WES) has emerged as a powerful tool for identifying causal variants in such unresolved cases. To identify the genetic basis of nondystrophinopathic MDs in Iranian families with inconclusive prior genetic testing and to evaluate the diagnostic yield and mutational spectrum in this population. Methods: We performed WES on one affected individual from each of 10 unrelated Iranian families with clinically diagnosed MD. Candidate variants were prioritized based on in silico prediction tools (SIFT, PolyPhen‐2, CADD, SpliceAI), population frequency databases (gnomAD, 1000 Genomes, EVS), and ACMG/AMP guidelines. Findings were validated by Sanger sequencing, MLPA, and STR haplotype analysis. Segregation analysis was performed in available family members. Results: WES led to a diagnostic yield of 69.2% (9/13 variants in 10 families) after segregation analysis and ACMG‐based reclassification. We identified 13 candidate variants in 10 known MD‐associated genes, including DYSF , SGCA , TK2 , MAP3K20 , LMNA , COL6A1 , COL6A2 , ITGA7 , MICU1 , and SGCB . Among these, seven variants (54%) were novel. The majority of cases (84.6%) followed an autosomal recessive pattern, consistent with high parental consanguinity (70%). Notably, a de novo splice‐site variant in COL6A2 (c.1053+1G>T) was identified in a sporadic case, confirming an autosomal dominant inheritance. Challenges in variant interpretation were observed in families with variants in tightly linked genes ( COL6A1 and COL6A2 ), highlighting the role of linkage disequilibrium in founder populations. Conclusion: WES is a highly effective diagnostic strategy for genetically heterogeneous MDs, particularly in consanguineous populations. Our study expands the mutational spectrum of MDs in Iran and provides critical data for genetic counseling, prenatal diagnosis, and future therapeutic development. The high rate of novel variants underscores the importance of population‐specific genomic studies.